GSK plc 13D/13G Filings for Telesis Bio, Inc. (TBIO)

GSK plc 13D and 13G filings for Telesis Bio, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2020-02-14
4:40 pm
Sale
2019-05-2913DTelesis Bio, Inc.
TBIO
GSK plc35,919
1.100%
-141,743decrease
(-79.78%)
Filing